Biophytis (DE:6XBA)
FRANKFURT:6XBA

Biophytis (DE:6XBA) Stock Price & Analysis

0 Followers

6XBA Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.30 - €4.04
Previous Close€0.55
Volume4.80K
Average Volume (3M)8.39K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€20.15M
Total Debt (Recent Filing)€14.41M
Price to Earnings (P/E)N/A
Beta0.79
Next EarningsFeb 27, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)N/A
Shares Outstanding20,396,575
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume2
30 Day Avg. Volume8,390
Price to Book (P/B)2.53
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.70
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside2451.92% Upside
Rating ConsensusModerate Buy
AlphaN/A
Number of Analyst Covering1


Financials

Annual

6XBA FAQ

What was Biophytis’s price range in the past 12 months?
Biophytis lowest stock price was €0.30 and its highest was €4.04 in the past 12 months.
    What is Biophytis’s market cap?
    Currently, no data Available
    When is Biophytis’s upcoming earnings report date?
    Biophytis’s upcoming earnings report date is Feb 27, 2023 which is in 20 days.
      How were Biophytis’s earnings last quarter?
      Biophytis released its earnings results on Jan 31, 2023. The company reported -€0.111 earnings per share for the quarter, beating the consensus estimate of -€0.121 by €0.009.
        Is Biophytis overvalued?
        According to Wall Street analysts Biophytis’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Biophytis pay dividends?
          Biophytis does not currently pay dividends.
          What is Biophytis’s EPS estimate?
          Biophytis’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Biophytis have?
          Currently, no data Available
          What happened to Biophytis’s price movement after its last earnings report?
          Biophytis reported an EPS of -€0.111 in its last earnings report, beating expectations of -€0.121. Following the earnings report the stock price went down -5.747%.
            Which hedge fund is a major shareholder of Biophytis?
            Currently, no hedge funds are holding shares in DE:6XBA

            ---

            Biophytis Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10
            This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
            Learn more about TipRanks Smart Score

            Company Description

            Biophytis

            Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.

            ---

            Forecast EPS vs Actual EPS


            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis